טוען...
The Anti-Factor Xa Range For Low Molecular Weight Heparin Thromboprophylaxis
Low molecular weight heparins (LMWHs) are now the mainstay option in the prevention and treatment of venous thromboembolism. In some patients receiving therapeutic doses of LMWH, activity can be measured by quantifying the presence of Anti-factor Xa (AFXa) for dose adjustment. However, currently the...
שמור ב:
| הוצא לאור ב: | Hematol Rep |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
PAGEPress Publications, Pavia, Italy
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4691677/ https://ncbi.nlm.nih.gov/pubmed/26733269 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/hr.2015.5844 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|